Effect of Birth on Immunological Parameters in Cord Blood

NCT ID: NCT03134768

Last Updated: 2020-04-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-02

Study Completion Date

2017-10-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood and also whether mode and duration of delivery has an influence on immune parameters in cord blood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immunologic Activity Alteration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

This is not an interventional study

This is an observational study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant mothers undergoing normal vaginal delivery

Exclusion Criteria

* Use of non-steroidal anti-inflammatory drugs (NSAIDs) 2 weeks prior to birth

* Antenatal antibiotics treatment (2 weeks prior to birth)
* Diabetes mellitus requiring insulin treatment during pregnancy
* Uncontrollable Hyperthyroidism during pregnancy
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Danone Asia Pacific Holdings Pte, Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elena Sandalova, PhD

Role: STUDY_CHAIR

Danone Asia Pacific Holdings Ltd

Anne Goh, MD

Role: STUDY_CHAIR

KK Hospital

Mei Chin Chua, MD

Role: PRINCIPAL_INVESTIGATOR

KK Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAE.1C.D.10

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.